Progress in microneedle array patch (MAP) for vaccine delivery

References

• Organization WH. Mortality and global health estimates. Geneva (Switzerland): World Health Organization. 2013 Retrieved May 4, 2020, from https://www.who.int/healthinfo/global_burden_disease/estimates/en/index1.html
   Google Scholar
• Shin CI, Jeong SD, Rejinold NS, Kim YC. Microneedles for vaccine delivery: challenges and future perspectives. Ther Deliv. 2017;8:447–60.
   PubMed Web of Science ®Google Scholar
• Arya J, Prausnitz MR. Microneedle patches for vaccination in developing countries. J Control Release. 2016;240:135–41.
   PubMed Web of Science ®Google Scholar
• Portnoy A, Ozawa S, Grewal S, Norman BA, Rajgopal J, Gorham KM, Haidari LA, Brown ST, Lee BY. Costs of vaccine programs across 94 low- and middle-income countries. Vaccine. 2015;33:A99–A108.
   PubMed Web of Science ®Google Scholar
• Restrepo-Méndez MC, Barros AJ, Wong KL, Johnson HL, Pariyo G, França GV, Wehrmeister FC, Victora CG. Inequalities in full immunization coverage: trends in low- and middle-income countries. Bull World Health Organ. 2016;94:794–805B.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Park JH. Human studies with microneedles for evaluation of their efficacy and safety. Expert Opin Drug Deliv. 2018;15:235–45.
   PubMed Web of Science ®Google Scholar
• Mathers AR, Larregina AT. Professional antigen-presenting cells of the skin. Immunol Res. 2006;36:127–36.
   PubMed Web of Science ®Google Scholar
• Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev. 2012;64:1547–68.
   PubMed Web of Science ®Google Scholar
• Mutyambizi K, Berger CL, Edelson RL. The balance between immunity and tolerance: the role of Langerhans cells. Cell Mol Life Sci. 2009;66:831–40.
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Alarcon JB, Brittingham JM, Sutter DE, Pettis RJ, Harvey NG. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med. 2002;8:415–19.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park J-H, Prausnitz MR. Dissolving microneedles for transdermal drug delivery. Biomaterials. 2008;29:2113–24.
   PubMed Web of Science ®Google Scholar
• Shim DH, Nguyen TT, Park P-G, Kim MJ, Park B-W, Jeong H-R, Kim D-S, Joo HW, Choi S-O, Park J-H, et al. Development of Botulinum Toxin A-Coated Microneedles for Treating Palmar Hyperhidrosis. Mol Pharm. 2019;16:4913–19.
   PubMedGoogle Scholar
• Lee JW, Choi SO, Felner EI, Prausnitz MR. Dissolving microneedle patch for transdermal delivery of human growth hormone. Small. 2011;7:531–39.
   PubMed Web of Science ®Google Scholar
• Morefield GL, Tammariello RF, Purcell BK, Worsham PL, Chapman J, Smith LA, Alarcon JB, Mikszta JA, Ulrich RG. An alternative approach to combination vaccines: intradermal administration of isolated components for control of anthrax, botulism, plague and staphylococcal toxic shock. J Immune Based Ther Vaccines. 2008;6:5.
   PubMedGoogle Scholar
• Amorij JP, Kersten GF, Saluja V, Tonnis WF, Hinrichs WL, Slutter B, Bal SM, Bouwstra JA, Huckriede A, Jiskoot W. Towards tailored vaccine delivery: needs, challenges and perspectives. J Control Release. 2012;161:363–76.
   PubMed Web of Science ®Google Scholar
• Wilson-Welder JH, Torres MP, Kipper MJ, Mallapragada SK, Wannemuehler MJ, Narasimhan B. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci. 2009;98:1278–316.
   PubMed Web of Science ®Google Scholar
• Vogt A, Combadiere B, Hadam S, Stieler KM, Lademann J, Schaefer H, Schaefer H, Autran B, Sterry W, Blume-Peytavi U. 40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin. J Invest Dermatol. 2006;126:1316–22.
   PubMed Web of Science ®Google Scholar
• Bal SM, Ding Z, Kersten GFA, Jiskoot W, Bouwstra JA. Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations. Pharm Res 2010;27:1837–47.
   PubMed Web of Science ®Google Scholar
• Siddhapura K, Harde H, Jain S. Immunostimulatory effect of tetanus toxoid loaded chitosan nanoparticles following microneedles assisted immunization. Nanomedicine. 2016;12:213–22.
   PubMed Web of Science ®Google Scholar
• Wang T, Zhen Y, Ma X, Wei B, Li S, Wang N. Mannosylated and lipid A-incorporating cationic liposomes constituting microneedle arrays as an effective oral mucosal HBV vaccine applicable in the controlled temperature chain. Colloids Surf B Biointerfaces. 2015;126:520–30.
   PubMed Web of Science ®Google Scholar
• Ding Z, Bal SM, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA. Transcutaneous immunization studies in mice using diphtheria toxoid-loaded vesicle formulations and a microneedle array. Pharm Res 2011;28:145–58.
   PubMed Web of Science ®Google Scholar
• Kumar A, Wonganan P, Sandoval MA, Li X, Zhu S, Cui Z. Microneedle-mediated transcutaneous immunization with plasmid DNA coated on cationic PLGA nanoparticles. J Control Release. 2012;163:230–39.
   PubMed Web of Science ®Google Scholar
• Yang HW, Ye L, Guo XD, Yang C, Compans RW, Prausnitz MR. Ebola Vaccination Using a DNA Vaccine Coated on PLGA-PLL/gammaPGA Nanoparticles Administered Using a Microneedle Patch. Adv Healthc Mater. 2017;6:1600750.
   Web of Science ®Google Scholar
• Yin D, Liang W, Xing S, Gao Z, Zhang W, Guo Z, Gao S. Hepatitis B DNA vaccine-polycation nano-complexes enhancing immune response by percutaneous administration with microneedle. Biol Pharm Bull. 2013;36:1283–91.
   PubMed Web of Science ®Google Scholar
• Boopathy AV, Mandal A, Kulp DW, Menis S, Bennett NR, Watkins HC, Wang W, Martin JT, Thai NT, He Y, et al. Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination. Proc Natl Acad Sci. 2019;116:16473–78.
   PubMed Web of Science ®Google Scholar
• Chen Y-H, Lai K-Y, Chiu Y-H, Wu Y-W, Shiau A-L, Chen M-C. Implantable microneedles with an immune-boosting function for effective intradermal influenza vaccination. Acta Biomaterialia. 2019; 97:230–38.
   Google Scholar
• Joyce JC, Sella HE, Jost H, Mistilis MJ, Esser ES, Pradhan P, Toy R, Collins ML, Rota PA, Roy K, et al. Extended delivery of vaccines to the skin improves immune responses. J Control Release. 2019;304:135–45.
   PubMed Web of Science ®Google Scholar
• Kim Y-C, Quan F-S, Compans RW, Kang S-M, Prausnitz MR. Formulation of microneedles coated with influenza virus-like particle vaccine. AAPS PharmSciTech. 2010;11:1193–201.
   PubMed Web of Science ®Google Scholar
• Shin JH, Noh JY, Kim KH, Park JK, Lee JH, Jeong SD, Jung DY, Song CS, Kim YC. Effect of zymosan and poly (I:C) adjuvants on responses to microneedle immunization coated with whole inactivated influenza vaccine. J Control Release. 2017;265:83–92.
   PubMed Web of Science ®Google Scholar
• Weldon WC, Martin MP, Zarnitsyn V, Wang B, Koutsonanos D, Skountzou I, Prausnitz MR, Compans RW. Microneedle vaccination with stabilized recombinant influenza virus hemagglutinin induces improved protective immunity. Clin Vaccine Immunol. 2011;18:647–54.
   PubMed Web of Science ®Google Scholar
• Nakatsukasa A, Kuruma K, Okamatsu M, Hiono T, Suzuki M, Matsuno K, Kida H, Oyamada T, Sakoda Y. Potency of whole virus particle and split virion vaccines using dissolving microneedle against challenges of H1N1 and H5N1 influenza viruses in mice. Vaccine. 2017;35:2855–61.
   PubMed Web of Science ®Google Scholar
• Shin JH, Park JK, Lee DH, Quan FS, Song CS, Kim YC. Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in Mice. PLoS One. 2015;10:e0130684.
   PubMed Web of Science ®Google Scholar
• Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, Murthy N, Compans RW, Skountzou I, Prausnitz MR. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16:915–20.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zarnitsyn VG, Ye L, Wen Z, Gao Y, Pan L, Skountzou I, Gill HS, Prausnitz MR, Yang C, et al. Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proc Natl Acad Sci U S A. 2009;106:7968–73.
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Martin MdP, Zarnitsyn VG, Sullivan SP, Compans RW, Prausnitz MR, Transdermal Influenza Immunization with Vaccine-Coated Microneedle Arrays. PLoS One. 2009;4:e4773.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity. J Control Release. 2010;142:187–95.
   PubMed Web of Science ®Google Scholar
• Kim M-C, Lee JW, Choi H-J, Lee Y-N, Hwang HS, Lee J, Kim C, Lee JS, Montemagno C, Prausnitz MR, et al. Microneedle patch delivery to the skin of virus-like particles containing heterologous M2e extracellular domains of influenza virus induces broad heterosubtypic cross-protection. J Control Release. 2015;210:208–16.
   PubMed Web of Science ®Google Scholar
• Wang BZ, Gill HS, He C, Ou C, Wang L, Wang YC, Feng H, Zhang H, Prausnitz MR, Compans RW. Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity. J Control Release. 2014;178:1–7.
   PubMed Web of Science ®Google Scholar
• Kim YC, Song JM, Lipatov AS, Choi SO, Lee JW, Donis RO, Compans RW, Kang SM, Prausnitz MR. Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch. Eur J Pharm Biopharm. 2012;81:239–47.
   PubMed Web of Science ®Google Scholar
• Song J-M, Kim Y-C OE, Compans RW, Prausnitz MR, Kang S-M. DNA vaccination in the skin using microneedles improves protection against influenza. Molecular Therapy: The Journal of the American Society of Gene Therapy. 2012;20:1472–80.
   PubMed Web of Science ®Google Scholar
• Quan F-S, Kim Y-C, Vunnava A, Yoo D-G, Song J-M, Prausnitz MR, Compans RW, Kang S-M. Intradermal vaccination with influenza virus-like particles by using microneedles induces protection superior to that with intramuscular immunization. J Virol. 2010;84:7760–69.
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Del Pilar Martin M, Zarnitsyn VG, Jacob J, Prausnitz MR, Compans RW, Skountzou I. Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccination. J Infect Dis. 2011;204:582–91.
   PubMed Web of Science ®Google Scholar
• Quan FS, Kim YC, Song JM, Hwang HS, Compans RW, Prausnitz MR, Kang SM. Long-term protective immunity from an influenza virus-like particle vaccine administered with a microneedle patch. Clin Vaccine Immunol. 2013;20:1433–39.
   PubMed Web of Science ®Google Scholar
• Kim Y-C, Yoo D-G, Compans RW, Kang S-M, Prausnitz MR. Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles. J Control Release. 2013;172:579–88.
   PubMed Web of Science ®Google Scholar
• Liu Y, Ye L, Lin F, Gomaa Y, Flyer D, Carrion R Jr., Patterson JL, Prausnitz MR, Smith G, Glenn G, et al. Intradermal Vaccination With Adjuvanted Ebola Virus Soluble Glycoprotein Subunit Vaccine by Microneedle Patches Protects Mice Against Lethal Ebola Virus Challenge. J Infect Dis. 2018;218:S545–s52.
   PubMed Web of Science ®Google Scholar
• Prow TW, Chen X, Prow NA, Fernando GJ, Tan CS, Raphael AP, Chang D, Ruutu MP, Jenkins DW, Pyke A, et al. Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice. Small. 2010;6:1776–84.
   PubMed Web of Science ®Google Scholar
• Zaric M, Becker PD, Hervouet C, Kalcheva P, Ibarzo Yus B, Cocita C, O’Neill LA, Kwon S-Y, Klavinskis LS. Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays. J Control Release. 2017;268:166–75. doi:10.1016/j.jconrel.2017.10.026.
   PubMed Web of Science ®Google Scholar
• Becker PD, Hervouet C, Mason GM, Kwon S-Y, Klavinskis LS. Skin vaccination with live virus vectored microneedle arrays induce long lived CD8+ T cell memory. Vaccine. 2015;33(37):4691–98. doi:10.1016/j.vaccine.2015.04.046.
   PubMed Web of Science ®Google Scholar
• Chen X, Kask AS, Crichton ML, McNeilly C, Yukiko S, Dong L, Marshak JO, Jarrahian C, Fernando GJ, Chen D, et al. Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays. J Control Release. 2010;148:327–33.
   PubMed Web of Science ®Google Scholar
• Kask AS, Chen X, Marshak JO, Dong L, Saracino M, Chen D, Jarrahian C, Kendall MA, Koelle DM. DNA vaccine delivery by densely-packed and short microprojection arrays to skin protects against vaginal HSV-2 challenge. Vaccine. 2010;28:7483–91.
   PubMed Web of Science ®Google Scholar
• Kim E, Erdos G, Huang S, Kenniston T, Falo LD Jr., Gambotto A. Preventative Vaccines for Zika Virus Outbreak: preliminary Evaluation. EBioMedicine. 2016;13:315–20.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Ye X, Ku Z, Liu Q, Shen C, Luo H, Luan H, Zhang C, Tian S, Lim C, et al. Transcutaneous immunization via rapidly dissolvable microneedles protects against hand-foot-and-mouth disease caused by enterovirus 71. J Control Release. 2016;243:291–302.
   PubMed Web of Science ®Google Scholar
• Joyce JC, Carroll TD, Collins ML, Chen MH, Fritts L, Dutra JC, Rourke TL, Goodson JL, McChesney MB, Prausnitz MR, et al. A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques. J Infect Dis. 2018;218:124–32.
   PubMed Web of Science ®Google Scholar
• Ding Z, Verbaan FJ, Bivas-Benita M, Bungener L, Huckriede A, van den Berg DJ, Kersten G, Bouwstra JA. Microneedle arrays for the transcutaneous immunization of diphtheria and influenza in BALB/c mice. J Control Release 2009;136:71–78.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wang F, Yang F, Wang Y, Zhang X, Sun S. Augmented humoral and cellular immune response of hepatitis B virus DNA vaccine by micro-needle vaccination using Flt3L as an adjuvant. Vaccine. 2010;28:1357–62.
   PubMed Web of Science ®Google Scholar
• Hirschberg H, van Kuijk S, Loch J, Jiskoot W, Bouwstra J, Kersten G, Amorij JP. A combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis B virus. Eur J Pharm Sci. 2012;46:1–7.
   PubMed Web of Science ®Google Scholar
• Guo L, Qiu Y, Chen J, Zhang S, Xu B, Gao Y. Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays. Biomed Microdevices. 2013;15:1077–85.
   PubMed Web of Science ®Google Scholar
• Ding Z, Van Riet E, Romeijn S, Kersten GF, Jiskoot W, Bouwstra JA. Immune modulation by adjuvants combined with diphtheria toxoid administered topically in BALB/c mice after microneedle array pretreatment. Pharm Res 2009;26:1635–43.
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Sullivan VJ, Dean C, Waterston AM, Alarcon JB, Dekker JP 3rd, Brittingham JM, Huang J, Hwang CR, Ferriter M, et al. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J Infect Dis. 2005;191:278–88.
   PubMed Web of Science ®Google Scholar
• Carey JB, Vrdoljak A, O’Mahony C, Hill AV, Draper SJ, Moore AC. Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route. Sci Rep. 2014;4:6154.
   PubMed Web of Science ®Google Scholar
• Pearson FE, O’Mahony C, Moore AC, Hill AV. Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine. Vaccine 2015;33:3248–55.
   PubMed Web of Science ®Google Scholar
• Carey JB, Pearson FE, Vrdoljak A, McGrath MG, Crean AM, Walsh PT, Doody T, O’Mahony C, Hill AVS, Moore AC. Microneedle Array Design Determines the Induction of Protective Memory CD8+ T Cell Responses Induced by a Recombinant Live Malaria Vaccine in Mice. PLoS One 2011;6:e22442.
   PubMed Web of Science ®Google Scholar
• Chen Y-C, Chen S-J, Cheng H-F, Yeh M-K. Development of Yersinia pestis F1 antigen-loaded liposome vaccine against plague using microneedles as a delivery system. J Drug Deliv Sci Technol. 2020;55:101443.
   Web of Science ®Google Scholar
• Dean CH, Alarcon JB, Waterston AM, Draper K, Early R, Guirakhoo F, Monath TP, Mikszta JA. Cutaneous delivery of a live, attenuated chimeric flavivirus vaccine against Japanese encephalitis (ChimeriVax)-JE) in non-human primates. Hum Vaccin. 2005;1:106–11.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Improved influenza vaccination in the skin using vaccine coated microneedles. Vaccine. 2009;27:6932–38.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Yoo DG, Compans RW, Kang SM, Prausnitz MR. Enhanced memory responses to seasonal H1N1 influenza vaccination of the skin with the use of vaccine-coated microneedles. J Infect Dis. 2010;201:190–98.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Song JM, Vunnava A, Yoo DG, Park KM, Compans RW, Kang SM, Prausnitz MR. Influenza immunization with trehalose-stabilized virus-like particle vaccine using microneedles. Procedia Vaccinol. 2010;2:15–19.
   PubMedGoogle Scholar
• Quan F-S, Kim Y-C, Compans RW, Prausnitz MR, Kang S-M. Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles. J Control Release. 2010;147:326–32.
   PubMed Web of Science ®Google Scholar
• Song JM, Kim YC, Barlow PG, Hossain MJ, Park KM, Donis RO, Prausnitz MR, Compans RW, Kang SM. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res. 2010;88:244–47.
   PubMed Web of Science ®Google Scholar
• Song J-M, Kim Y-C, Lipatov AS, Pearton M, Davis CT, Yoo D-G, Park K-M, Chen L-M, Quan F-S, Birchall JC, et al. Microneedle delivery of H5N1 influenza virus-like particles to the skin induces long-lasting B- and T-cell responses in mice. Clin Vaccine Immunol. 2010;17:1381–89.
   PubMed Web of Science ®Google Scholar
• Jeong H-R, Park S, Park J-H, Bae J-Y, Kim G-Y, Baek S-K, Park M-S, Park J-H. Preparation of H1N1 microneedles by a low-temperature process without a stabilizer. Eur J Pharm Biopharm. 2019;143:1–7.
   PubMed Web of Science ®Google Scholar
• Del Pilar Martin M, Weldon WC, Zarnitsyn VG, Koutsonanos DG, Akbari H, Skountzou I, Jacob J, Prausnitz MR, Compans RW. Local response to microneedle-based influenza immunization in the skin. MBio. 2012;3:e00012–12.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Chen X, Primiero CA, Yukiko SR, Fairmaid EJ, Corbett HJ, Frazer IH, Brown LE, Kendall MA. Nanopatch targeted delivery of both antigen and adjuvant to skin synergistically drives enhanced antibody responses. J Control Release. 2012;159:215–21.
   PubMed Web of Science ®Google Scholar
• Fernando GJP, Chen X, Prow TW, Crichton ML, Fairmaid EJ, Roberts MS, Frazer IH, Brown LE, Kendall MAF. Potent Immunity to Low Doses of Influenza Vaccine by Probabilistic Guided Micro-Targeted Skin Delivery in a Mouse Model. PLoS One. 2010;5:e10266.
   PubMed Web of Science ®Google Scholar
• Chen X, Corbett HJ, Yukiko SR, Raphael AP, Fairmaid EJ, Prow TW, Brown LE, Fernando GJP, Kendall MAF. Site-Selectively Coated, Densely-Packed Microprojection Array Patches for Targeted Delivery of Vaccines to Skin. Adv Funct Mater. 2010;21:464–73.
   Web of Science ®Google Scholar
• Chen X, Fernando GJ, Crichton ML, Flaim C, Yukiko SR, Fairmaid EJ, Corbett HJ, Primiero CA, Ansaldo AB, Frazer IH, et al. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Control Release. 2011;152:349–55.
   PubMed Web of Science ®Google Scholar
• Depelsenaire ACI, Meliga SC, McNeilly CL, Pearson FE, Coffey JW, Haigh OL, Flaim CJ, Frazer IH, Kendall MAF. Colocalization of cell death with antigen deposition in skin enhances vaccine immunogenicity. J Invest Dermatol 2014;134:2361–70.
   PubMed Web of Science ®Google Scholar
• Koutsonanos DG, Vassilieva EV, Stavropoulou A, Zarnitsyn VG, Esser ES, Taherbhai MT, Prausnitz MR, Compans RW, Skountzou I. Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection. Sci Rep. 2012;2:357.
   PubMed Web of Science ®Google Scholar
• Weldon WC, Zarnitsyn VG, Esser ES, Taherbhai MT, Koutsonanos DG, Vassilieva EV, Skountzou I, Prausnitz MR, Compans RW. Effect of Adjuvants on Responses to Skin Immunization by Microneedles Coated with Influenza Subunit Vaccine. PLoS One. 2012;7:e41501.
   PubMed Web of Science ®Google Scholar
• Fernando GJ, Zhang J, Ng HI, Haigh OL, Yukiko SR, Kendall MA. Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses. J Control Release. 2016;237:35–41.
   PubMed Web of Science ®Google Scholar
• Gill HS, Soderholm J, Prausnitz MR, Sallberg M. Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine. Gene Ther. 2010;17:811–14.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Choi J-A, Kim JS, Park H, Yang E, Lee WJ, Baek S-K, Song M, Park J-H. Skin immunization with third-generation hepatitis B surface antigen using microneedles. Vaccine. 2019;37(40):5954–61. doi:10.1016/j.vaccine.2019.08.036.
   PubMed Web of Science ®Google Scholar
• Schipper P, van der Maaden K, Groeneveld V, Ruigrok M, Romeijn S, Uleman S, Oomens C, Kersten G, Jiskoot W, Bouwstra J. Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice. J Control Release. 2017;262:28–36.
   PubMed Web of Science ®Google Scholar
• Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31:3396–402.
   PubMed Web of Science ®Google Scholar
• Jung D, Rejinold NS, Kwak JE, Park SH, Kim YC. Nano-patterning of a stainless steel microneedle surface to improve the dip-coating efficiency of a DNA vaccine and its immune response. Colloids Surf B Biointerfaces. 2017;159:54–61.
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, McGrath MG, Carey JB, Draper SJ, Hill AV, O’Mahony C, Crean AM, Moore AC. Coated microneedle arrays for transcutaneous delivery of live virus vaccines. J Control Release. 2012;159:34–42.
   PubMed Web of Science ®Google Scholar
• Muller DA, Depelsenaire ACI, Shannon AE, Watterson D, Corrie SR, Owens NS, Agyei-Yeboah C, Cheung STM, Zhang J, Fernando GJP, et al. Efficient delivery of Dengue virus subunit vaccines to the skin by microprojection arrays. Vaccines (Basel). 2019;7(189):1–13.
   Google Scholar
• Chandler CE, Harberts EM, Laemmermann T, Zeng Q, Opene BN, Germain RN, Jewell CM, Scott AJ, Ernst RK. Intradermal Delivery of Bacteria by Using Microneedle Arrays. Infect Immun. 2018;86:e00406–18.
   PubMed Web of Science ®Google Scholar
• Pearson FE, McNeilly CL, Crichton ML, Primiero CA, Yukiko SR, Fernando GJP, Chen X, Gilbert SC, Hill AVS, Kendall MAF. Dry-Coated Live Viral Vector Vaccines Delivered by Nanopatch Microprojections Retain Long-Term Thermostability and Induce Transgene-Specific T Cell Responses in Mice. PLoS One 2013;8:e67888.
   PubMed Web of Science ®Google Scholar
• Moreno E, Schwartz J, Calvo A, Blanco L, Larrea E, Irache JM, Sanmartin C, Coulman SA, Soto M, Birchall JC, et al. Skin vaccination using microneedles coated with a plasmid DNA cocktail encoding nucleosomal histones of Leishmania spp. Int J Pharm. 2017;533:236–44.
   PubMedGoogle Scholar
• Edens C, Collins ML, Ayers J, Rota PA, Prausnitz MR. Measles vaccination using a microneedle patch. Vaccine. 2013;31:3403–09.
   PubMed Web of Science ®Google Scholar
• Muller DA, Pearson FE, Fernando GJ, Agyei-Yeboah C, Owens NS, Corrie SR, Crichton ML, Wei JC, Weldon WC, Oberste MS, et al. Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses. Sci Rep 2016;6:22094.
   PubMed Web of Science ®Google Scholar
• van der Maaden K, Sekerdag E, Schipper P, Kersten G, Jiskoot W, Bouwstra J. Layer-by-Layer Assembly of Inactivated Poliovirus and N-Trimethyl Chitosan on pH-Sensitive Microneedles for Dermal Vaccination. Langmuir. 2015;31:8654–60.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Bonificio A, Gallorini S, Palladino G, Determan AS, Dohmeier DM, Kroells KD, Sternjohn JR, Singh M, et al. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine. 2013;31:3435–41.
   PubMed Web of Science ®Google Scholar
• Ma Y, Tao W, Krebs SJ, Sutton WF, Haigwood NL, Gill HS. Vaccine delivery to the oral cavity using coated microneedles induces systemic and mucosal immunity. Pharm Res. 2014;31:2393–403.
   PubMed Web of Science ®Google Scholar
• Andrianov AK, DeCollibus DP, Gillis HA, Kha HH, Marin A, Prausnitz MR, Babiuk LA, Townsend H, Mutwiri G. Poly[di(carboxylatophenoxy)phosphazene] is a potent adjuvant for intradermal immunization. Proc Natl Acad Sci U S A. 2009;106:18936–41.
   PubMed Web of Science ®Google Scholar
• Hiraishi Y, Nandakumar S, Choi SO, Lee JW, Kim YC, Posey JE, Sable SB, Prausnitz MR. Bacillus Calmette-Guerin vaccination using a microneedle patch. Vaccine. 2011;29:2626–36.
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Li AV, Abbink P, Liu J, Li H, Stanley KA, Smith KM, Lavine CL, Seaman MS, Kramer JA, et al. Vaccine delivery with microneedle skin patches in nonhuman primates. Nat Biotechnol. 2013;31:1082–85.
   PubMed Web of Science ®Google Scholar
• DeMuth PC, Min Y, Huang B, Kramer JA, Miller AD, Barouch DH, Hammond PT, Irvine DJ. Polymer multilayer tattooing for enhanced DNA vaccination. Nat Mater. 2013;12:367.
   PubMed Web of Science ®Google Scholar
• Choi YH, Perez-Cuevas MB, Kodani M, Zhang X, Prausnitz MR, Kamili S, O’Connor SM. Feasibility of Hepatitis B Vaccination by Microneedle Patch: cellular and Humoral Immunity Studies in Rhesus Macaques. J Infect Dis. 2019;220:1926–34.
   Web of Science ®Google Scholar
• Koutsonanos DG, Esser ES, McMaster SR, Kalluri P, Lee JW, Prausnitz MR, Skountzou I, Denning TL, Kohlmeier JE, Compans RW. Enhanced immune responses by skin vaccination with influenza subunit vaccine in young hosts. Vaccine. 2015;33:4675–82.
   PubMed Web of Science ®Google Scholar
• Vrdoljak A, Allen EA, Ferrara F, Temperton NJ, Crean AM, Moore AC. Induction of broad immunity by thermostabilised vaccines incorporated in dissolvable microneedles using novel fabrication methods. J Control Release. 2016;225:192–204.
   PubMed Web of Science ®Google Scholar
• Vassilieva EV, Kalluri H, McAllister D, Taherbhai MT, Esser ES, Pewin WP, Pulit-Penaloza JA, Prausnitz MR, Compans RW, Skountzou I. Improved immunogenicity of individual influenza vaccine components delivered with a novel dissolving microneedle patch stable at room temperature. Drug Deliv Transl Res. 2015;5:360–71.
   PubMed Web of Science ®Google Scholar
• Raphael AP, Prow TW, Crichton ML, Chen X, Fernando GJ, Kendall MA. Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays. Small. 2010;6:1785–93.
   PubMed Web of Science ®Google Scholar
• Kommareddy S, Baudner BC, Oh S, Kwon SY, Singh M, O’Hagan DT. Dissolvable microneedle patches for the delivery of cell-culture-derived influenza vaccine antigens. J Pharm Sci. 2012;101:1021–27.
   PubMed Web of Science ®Google Scholar
• Wang J, Li B, Wu MX. Effective and lesion-free cutaneous influenza vaccination. Proc Natl Acad Sci U S A. 2015;112:5005–10.
   PubMed Web of Science ®Google Scholar
• Stinson JA, Raja WK, Lee S, Kim HB, Diwan I, Tutunjian S, Panilaitis B, Omenetto FG, Tzipori S, Kaplan DL. Silk Fibroin Microneedles for Transdermal Vaccine Delivery. ACS Biomaterials Science & Engineering. 2017;3:360–69.
   PubMed Web of Science ®Google Scholar
• Ono A, Azukizawa H, Ito S, Nakamura Y, Asada H, Quan YS, Kamiyama F, Katayama I, Hirobe S, Okada N. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery. Int J Pharm. 2017;532:374–83.
   PubMed Web of Science ®Google Scholar
• Schepens B, Vos PJ, Saelens X. van der Maaden K. Vaccination with influenza hemagglutinin-loaded ceramic nanoporous microneedle arrays induces protective immune responses. Eur J Pharm Biopharm. 2019;136:259–66.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Guo L, Zhang S, Xu B, Gao Y, Hu Y, Hou J, Bai B, Shen H, Mao P. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN. Drug Deliv. 2016;23:2391–98.
   PubMed Web of Science ®Google Scholar
• Perez Cuevas MB, Kodani M, Choi Y, Joyce J, O’Connor SM, Kamili S, Prausnitz MR. Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques. Bioengineering & Translational Medicine. 2018;3(3):186–96. doi:10.1002/btm2.10098.
   PubMed Web of Science ®Google Scholar
• Bachy V, Hervouet C, Becker PD, Chorro L, Carlin LM, Herath S, Papagatsias T, Barbaroux J-B, Oh S-J, Benlahrech A. Langerin negative dendritic cells promote potent CD8+ T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays. Proc Natl Acad Sci. 2013;110(8):3041. doi:10.1073/pnas.1214449110.
   PubMed Web of Science ®Google Scholar
• Pattani A, McKay PF, Garland MJ, Curran RM, Migalska K, Cassidy CM, Malcolm RK, Shattock RJ, McCarthy HO, Donnelly RF. Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations. J Control Release. 2012;162(3):529–37. doi:10.1016/j.jconrel.2012.07.039.
   PubMed Web of Science ®Google Scholar
• Zaric M, Becker PD, Hervouet C, Kalcheva P, Doszpoly A, Blattman N, A. O’ Neill L, Yus BI, Cocita C, Kwon S-Y, et al. Skin immunisation activates an innate lymphoid cell-monocyte axis regulating CD8+ effector recruitment to mucosal tissues. Nat Commun. 2019;10(1):2214. doi:10.1038/s41467-019-09969-2.
   PubMedGoogle Scholar
• Turvey ME, Uppu DSSM, Mohamed Sharif AR, Bidet K, Alonso S, Ooi EE, Ooi EE, Hammond PT. Microneedle-based intradermal delivery of stabilized dengue virus. Bioengineering & Transla Med. 2019;4:e10127.
   PubMed Web of Science ®Google Scholar
• Resch TK, Wang Y, Moon -S-S, Joyce J, Li S, Prausnitz M, Jiang B. Inactivated rotavirus vaccine by parenteral administration induces mucosal immunity in mice. Sci Rep. 2018;8:561.
   PubMed Web of Science ®Google Scholar
• Donadei A, Kraan H, Ophorst O, Flynn O, O’Mahony C, Soema PC, Moore AC. Skin delivery of trivalent Sabin inactivated poliovirus vaccine using dissolvable microneedle patches induces neutralizing antibodies. J Control Release. 2019;311-312:96–103.
   PubMed Web of Science ®Google Scholar
• Hsueh KJ, Chen MC, Cheng LT, Lee JW, Chung WB, Chu CY. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles. Comp Immunol Microbiol Infect Dis. 2017;50:78–87.
   PubMed Web of Science ®Google Scholar
• Liu S, Zhang S, Duan Y, Niu Y, Gu H, Zhao Z, Zhang S, Yang Y, Wang X, Gao Y. Transcutaneous immunization of recombinant Staphylococcal enterotoxin B protein using a dissolving microneedle provides potent protection against lethal enterotoxin challenge. Vaccine. 2019;37:3810–19.
   PubMed Web of Science ®Google Scholar
• Chen F, Yan Q, Yu Y, Wu MX. BCG vaccine powder-laden and dissolvable microneedle arrays for lesion-free vaccination. J Control Release. 2017;255:36–44.
   PubMed Web of Science ®Google Scholar
• Gala RP, Zaman RU, D’Souza MJ, Zughaier SM. Novel Whole-Cell Inactivated Neisseria Gonorrhoeae Microparticles as Vaccine Formulation in Microneedle-Based Transdermal Immunization. Vaccines (Basel). 2018;6:1–17.
   Web of Science ®Google Scholar
• Rodgers AM, MTC M, Vincente-Perez EM, Dubois AV, Ingram RJ, Larraneta E, Kissenpfennig A, Donnelly RF. Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: A proof of concept study. Int J Pharm. 2018;549:87–95.
   PubMedGoogle Scholar
• Lee C, Kim H, Kim S, Lahiji SF, Ha NY, Yang H, Kang G, Nguyen HYT, Kim Y, Choi MS, et al. Comparative Study of Two Droplet-Based Dissolving Microneedle Fabrication Methods for Skin Vaccination. Adv Healthc Mater. 2018;7:e1701381.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Hirobe S, Yokota Y, Ayabe Y, Seto M, Quan YS, Kamiyama F, Tougan T, Horii T, Mukai Y, et al. Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza. J Control Release. 2012;160:495–501.
   PubMed Web of Science ®Google Scholar
• Arshad MS, Fatima S, Nazari K, Ali R, Farhan M, Muhammad SA, Abbas N, Hussain A, Kucuk I, Chang M-W, et al. Engineering and characterisation of BCG-loaded polymeric microneedles. J Drug Target. 2019;28:525–32.
   PubMed Web of Science ®Google Scholar
• Bonificio A, Ghartey-Tagoe E, Gallorini S, Baudner B, Chen G, Singh P, O’Hagan DT, Kommareddy S. Fabrication of cell culture-derived influenza vaccine dissolvable microstructures and evaluation of immunogenicity in guinea pigs. Vaccine. 2015;33:2930–38.
   PubMed Web of Science ®Google Scholar
• Poirier D, Renaud F, Dewar V, Strodiot L, Wauters F, Janimak J, Shimada T, Nomura T, Kabata K, Kuruma K, et al. Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable. Biomaterials. 2017;145:256–65.
   PubMed Web of Science ®Google Scholar
• Christiansen D, Earnest-Silveira L, Grubor-Bauk B, Wijesundara DK, Boo I, Ramsland PA, Vincan E, Drummer HE, Gowans EJ, Torresi J. Pre-clinical evaluation of a quadrivalent HCV VLP vaccine in pigs following microneedle delivery. Sci Rep. 2019;9:9251.
   PubMed Web of Science ®Google Scholar
• Arya JM, Dewitt K, Scott-Garrard M, Chiang YW, Prausnitz MR. Rabies vaccination in dogs using a dissolving microneedle patch. J Control Release. 2016;239:19–26.
   PubMed Web of Science ®Google Scholar
• Edens C, Dybdahl-Sissoko NC, Weldon WC, Oberste MS, Prausnitz MR. Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque. Vaccine. 2015;33:4683–90.
   PubMed Web of Science ®Google Scholar
• Edens C, Collins ML, Goodson JL, Rota PA, Prausnitz MR. A microneedle patch containing measles vaccine is immunogenic in non-human primates. Vaccine. 2015;33:4712–18.
   PubMed Web of Science ®Google Scholar
• Esser ES, Romanyuk A, Vassilieva EV, Jacob J, Prausnitz MR, Compans RW, Skountzou I. Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy. J Control Release. 2016;236:47–56.
   PubMed Web of Science ®Google Scholar
• Mikszta JA, Dekker JP 3rd, Harvey NG, Dean CH, Brittingham JM, Huang J, Sullivan VJ, Dyas B, Roy CJ, Ulrich RG. Microneedle-based intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun. 2006;74:6806–10.
   PubMed Web of Science ®Google Scholar
• Kim YC, Quan FS, Compans RW, Kang SM, Prausnitz MR. Stability kinetics of influenza vaccine coated onto microneedles during drying and storage. Pharm Res. 2011;28:135–44.
   PubMed Web of Science ®Google Scholar
• Chu LY, Ye L, Dong K, Compans RW, Yang C, Prausnitz MR. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches. Pharm Res. 2016;33:868–78.
   PubMed Web of Science ®Google Scholar
• Mistilis MJ, Joyce JC, Esser ES, Skountzou I, Compans RW, Bommarius AS, Prausnitz MR Long-term stability of influenza vaccine in a dissolving microneedle patch. Drug Deliv Transl Res. 2017;7:195–205.
   PubMed Web of Science ®Google Scholar
• Hiraishi Y, Nakagawa T, Quan YS, Kamiyama F, Hirobe S, Okada N, Nakagawa S. Performance and characteristics evaluation of a sodium hyaluronate-based microneedle patch for a transcutaneous drug delivery system. Int J Pharm. 2013;441:570–79.
   PubMed Web of Science ®Google Scholar
• Griffin P, Elliott S, Krauer K, Davies C, Rachel Skinner S, Anderson CD, Forster A. Safety, acceptability and tolerability of uncoated and excipient-coated high density silicon micro-projection array patches in human subjects. Vaccine. 2017;35:6676–84.
   PubMed Web of Science ®Google Scholar
• Fernando GJP, Hickling J, Jayashi Flores CM, Griffin P, Anderson CD, Skinner SR, Davies C, Witham K, Pryor M, Bodle J, et al. Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™). Vaccine. 2018;36:3779–88.
   PubMed Web of Science ®Google Scholar
• Arya J, Henry S, Kalluri H, McAllister DV, Pewin WP, Prausnitz MR. Tolerability, usability and acceptability of dissolving microneedle patch administration in human subjects. Biomaterials. 2017;128:1–7.
   PubMed Web of Science ®Google Scholar
• Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, Pewin W, Frew PM, Yu T, Thornburg NJ, et al. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial. The Lancet. 2017;390:649–58.
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Hanafusa T, Matsuo K, Quan YS, Kamiyama F, Katayama I, Okada N, Nakagawa S Clinical study and stability assessment of a novel transcutaneous influenza vaccination using a dissolving microneedle patch. Biomaterials. 2015;57:50–58.
   PubMed Web of Science ®Google Scholar
• Laurent PE, Bourhy H, Fantino M, Alchas P, Mikszta JA. Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults. Vaccine. 2010;28:5850–56.
   PubMed Web of Science ®Google Scholar
• Daddona PE, Matriano JA, Mandema J, Maa Y-F. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res. 2011;28:159–65.
   PubMed Web of Science ®Google Scholar
• Hirobe S, Azukizawa H, Matsuo K, Zhai Y, Quan YS, Kamiyama F, Suzuki H, Katayama I, Okada N, Nakagawa S. Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device. Pharm Res. 2013;30:2664–74.
   PubMed Web of Science ®Google Scholar
• Indermun S, Luttge R, Choonara YE, Kumar P. du Toit LC, Modi G, Pillay V. Current Advances in the Fabrication of Microneedles for Transdermal Delivery J Control Release. 2014;185:130–38.
   PubMed Web of Science ®Google Scholar
• Mikolaj Milewski YK, Ding Z, Zhang J, Ghartey-Tagoe E, Manser K, Nissley B, Petrescu I, Xu L, Duffield B, Chen G, et al. Stabilization and transdermal delivery of an investigational peptide using Microcor® solid-state dissolving microstructure arrays. J Pharm Sci. 2020;109:1288–96.
   PubMed Web of Science ®Google Scholar
• Norman JJ, Arya JM, McClain MA, Frew PM, Meltzer MI, Prausnitz MR. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine. 2014;32:1856–62.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin. Annu Rev Chem Biomol Eng. 2017;8:177–200.
   PubMed Web of Science ®Google Scholar
• Commission E. Chapter 1: pharmaceutical Quality System Legal. EudraLex Good Manuf Pract Guidel. 2013;4:1–8.
   Google Scholar
• Lutton RE, Moore J, Larraneta E, Ligett S, Woolfson AD, Donnelly RF. Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation. Drug Deliv Transl Res. 2015;5:313–31.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Brown K, Siebenaler K, Determan A, Dohmeier D, Hansen K. Development of lidocaine-coated microneedle product for rapid, safe, and prolonged local analgesic action. Pharm Res. 2012;29:170–77.
   PubMed Web of Science ®Google Scholar
• Richter-Johnson J, Kumar P, Choonara YE. du Toit LC, Pillay V. Therapeutic Applications and Pharmacoeconomics of Microneedle Technology Expert Rev Pharmacoecon Outcomes Res. 2018;18:359–69.
   PubMed Web of Science ®Google Scholar
• Forster AH, Witham K, Depelsenaire AC, Veitch M, Wells JW, Wheatley A, Pryor M, Lickliter JD, Francis B, Rockman S. Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: results from a randomized, controlled phase I clinical trial. PLoS Med. 2020;17:e1003024.
   PubMed Web of Science ®Google Scholar
• Kennedy RB, Tosh PK, Goergen KM, Grill DE, Oberg AL, Poland GA. Statistical modeling using early markers of innate immunity to explain variation in humoral responses to influenza vaccine in older adults. Vaccine 2015;33:3682–88.
   PubMed Web of Science ®Google Scholar
• Kim NW, Kim S-Y, Lee JE, Yin Y, Lee JH, Lim SY, Kim ES, Duong HTT, Kim HK, Kim S. Enhanced cancer vaccination by in situ nanomicelle-generating dissolving microneedles. ACS Nano. 2018;12:9702–13.
   PubMed Web of Science ®Google Scholar
• Lee C, Kim H, Kim S, Lahiji SF, Ha NY, Yang H, Kang G, Nguyen HYT, Kim Y, Choi MS. Comparative Study of Two Droplet‐Based Dissolving Microneedle Fabrication Methods for Skin Vaccination. Adv Healthc Mater. 2018;7:1701381.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. Combination products therapeutic and diagnostic products that combine drugs, devices, and/or biological products. [Accessed 2018 Dec 18]. https://www.fda.gov/CombinationProducts
   Google Scholar
• Peyraud N, Zehrung D, Jarrahian C, Frivold C, Orubu T, Giersing B. Potential use of microarray patches for vaccine delivery in low- and middle- income countries. Vaccine. 2019;37:4427–34.
   PubMed Web of Science ®Google Scholar
• Dellepiane N,DW. Twenty-five years of eht WHO vaccines prequalification programme (1987-2012): lessons learned and future perspectives. Vaccine. 2015;33:52–61.
   PubMed Web of Science ®Google Scholar